A funded agtech company is the correct initial payer for evidence boundary crossing.
Status
Open
Not yet tested; the decisive observation has not been made.
Market research and pricing work only. No invoiced instance.
Gate G5Falsifier statedNext test stated
Why it matters
The consequence of being wrong
If false
The payer architecture is wrong and the go-to-market must be rebuilt.
If true
There is a fundable buyer before institutional procurement matures.
Current support
Pricing dossierBuyer interviewsMarket structure analysis
Missing proof
Paid production conversion.
Falsifier
Developers adopt, and budget owners repeatedly refuse paid evidence operation.
Next decisive test
One named startup pays for readiness or deployment.
Connected views
The same claim in three other languages
Independent review
Everything in this room
Related views